Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: Association with p53 expression

Human Pathology

Volumn 28, Issue 5, 1997, Pages 556-562

  Sheu, Lai Fa ^a   Chen, Ann ^b   Meng, Ching Liang ^b   Ho, Kuo Chieh ^b   Lin, Fu Gong ^b   Lee, Wei Hwa ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

bcl 2; nasopharyngeal carcinoma; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; DYSPLASIA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0030919604     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90078-2     Document Type: Article

References (39)

1. Tsujimoto Y, Cossman J, Jaffe E, et al: Involvement of the bcl- 2 gene in human follicular lymphoma. Science 228:1440-1443, 1985
2. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNA for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28, 1986
3. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 in an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
4. Monaghan P, Robertson D, Amos TAS, et al: Ultrastructural localization of bcl-2 protein. J Histochem Cytochem 40:1819-1825, 1992
5. Hockenbery DM, Nutter M, Hickey W, et al: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961-6965, 1991
6. LeBrun DP, Warnke RA, Cleary ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743-753, 1993
7. Reed JC, Cuddy M, Slabiak T, et al: Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature 336:259-261, 1988
8. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254-256, 1991
9. McDonnell TJ, Nunez G, Platt FM, et al: Deregulated bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 10:1901-1907, 1990
10. Ramani P, Lu QL: Expression of bcl-2 gene product in neuroblastoma. J Pathol 172:273-278, 1994
11. McDonnell TJ, Troncoso P, Brisbay SM, et al: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944, 1992
12. Colombel M, Symmans F, Gil S, et al: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. AmJ Pathol 143:390-400, 1993
13. Doglioni C, Dei Tos AP, Laurino L, et al: The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 424:47-51, 1994
14. Bhargava V, Kell DL, van de Rijn M, et al: Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535-540, 1994
15. Joensuu H, Pylkkanen L, Toikkanen S: bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198, 1994
16. Pilotti S, Collini P, Rilke F, et al: Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337-342, 1994
17. Pezzella F, Turley H, Kuzu I, et al: bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
18. Lu QL, Elia G, Lucas S, et al: Bcl-2 protooncogene expression in Epstein-Barr virus associated nasopharyngeal carcinoma. Int J Cancer 53:29-35, 1993
19. Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutation in human cancers. Science 253:49-53, 1991
20. Sheu LF, Chen A, Tseng HH, et al: Assessment of p53 expression in nasopharyngeal carcinoma. HUM PATHOL 26:380-386, 1995
21. Locker J: Tumor suppressor genes and the practice of surgical pathology. HUM PATHOL 26:359-361, 1995
22. Bennett WP, Colby TV, Travis WD, et al: p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 53:4817-4822, 1993
23. Przygodzki RM, Finkelstein SD, Langer JC, et al: Analysis of p53, K-ras-2, and C-raf-1, in 'pulmonary neuroendocrine tumors: Correlation with histological subtype and clinical outcome. Am J Pathol 148:1531-1541, 1996
24. Shanmugaratnam K, Sobin L: Histological typing of upper respiratory tract tumors, in International Histological Typing of Tumors, no. 19. Geneva, Switzerland, World Health Organization, 1978, pp 32-33
25. Shanmugaratnam K, Chan SH, De-The G, et al: Histopathology of nasopharyngeal carcinoma: Correlation with epidemiology, survival rates and other biological characteristics. Cancer 44:1029-1044, 1979
26. World Health Organization: Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland, World Health Organization, 1987
27. Bankfalvi A, Navabi H, Bier B, et al: Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 174:223-228, 1994
28. Krueger GRF, Kottaridis SD, Wolf H, et al: Histological types of nasopharyngeal carcinoma as compared to EBV serology. Anticancer Res 1:187-194, 1981
29. Bronner MP, Culin C, Reed JC, et al: The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. AmJ Pathol 146:20-26, 1995
30. Pezzella F, Morrison H, Jones M, et al: Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 22:39-44, 1993
31. Niedobitek G, Agathanggelou A, Barber P, et al: p53 Overexpression an Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 170:457-461, 1993
32. Spruck III CH, Tsai YC, Huang DP, et al: Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res 52:4787-4790, 1992
33. Sun Y, Hegamyer G, Cheng YJ, et al: An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sei U S A 89:6516-6520, 1992
34. Effert P, McCoy R, Abdel-Hamid M, et al: Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 66:3768-3775, 1992
35. Kennedy SM, Macgeogh C, Jaffe R, et al: Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood dose not correlate with gene mutations. HUM PATHOL 25:438-442, 1994
36. Xerri Ll, Pare P, Bouabdallah R, et al: PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease. J Pathol 175:189-194, 1995
37. Xu L, Chen YT, Huvos AG, et al: Overexpression of p53 protein in squamous cell carcinoma of head and neck without apparent gene mutations. Diagn Mol Pathol 3:83-92, 1994
38. Malkin D, Sexsmith E, Yeger H, et al: Mutations of the p53 tumor suppressor gene occur infrequently in Wilm's tumor. Cancer Res 54:2077-2079, 1994
39. Matsushima AY, Gesarman E, Chadburn A, et al: Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Am J Pathol 144:573-584, 1994